Published in Diabetes on December 01, 1976
Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest (1978) 1.52
Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. J Clin Invest (1979) 1.46
Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings. J Clin Invest (1978) 1.02
Regulation of glucagon secretion in normal and diabetic human islets by γ-hydroxybutyrate and glycine. J Biol Chem (2012) 1.00
Blood glutamate scavenging: insight into neuroprotection. Int J Mol Sci (2012) 0.95
Effects of starvation on the maximal activities of some glycolytic and citric acid-cycle enzymes and glutaminase in mucosa of the small intestine of the rat. Biochem J (1982) 0.92
Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose. J Clin Invest (1978) 0.91
Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes (2012) 0.88
Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects. Gut (1979) 0.86
The Neuropeptide Allatostatin A Regulates Metabolism and Feeding Decisions in Drosophila. Sci Rep (2015) 0.84
Neutralization of glucagon by antiserum as a tool in glucagon physiology. Lack of depression of basal blood glucose after antiserum treatment in rats. J Clin Invest (1978) 0.79
Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes. Cell Rep (2016) 0.78
Somatostatinoma--the most recently described pancreatic islet cell tumor. West J Med (1985) 0.75
Studies on a stable, mild diabetes induced by streptozotocin in rats. Br J Exp Pathol (1982) 0.75
The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes (1981) 7.28
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest (1985) 4.38
Plasma amino acid levels and insulin secretion in obesity. N Engl J Med (1969) 4.18
Amino acid metabolism during prolonged starvation. J Clin Invest (1969) 4.06
Liver and kidney metabolism during prolonged starvation. J Clin Invest (1969) 3.47
Alanine: key role in gluconeogenesis. Science (1970) 3.43
The glucose-alanine cycle. Metabolism (1973) 3.43
Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med (1992) 3.42
The multiple risk factor intervention trial (MRFIT) II. The development of the protocol. Prev Med (1981) 3.02
Leg blood flow during exercise in man. Clin Sci (1971) 2.97
Amino acid balance across tissues of the forearm in postabsorptive man. Effects of insulin at two dose levels. J Clin Invest (1969) 2.94
Amino acid metabolism in man. Annu Rev Biochem (1975) 2.88
Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes (1983) 2.45
Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J Clin Invest (1974) 2.40
Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest (1996) 2.33
Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man. J Clin Invest (1971) 2.29
Amino acid metabolism in exercising man. J Clin Invest (1971) 2.29
Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest (1976) 2.27
Glucose metabolism during leg exercise in man. J Clin Invest (1971) 2.27
13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes (1998) 2.21
Is skin preparation necessary before insulin injection? Lancet (1978) 2.15
Nonproductive exchanges: the use of isotopes gone astray. Metabolism (1992) 2.12
Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest (1972) 2.11
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A (1978) 2.08
Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes (1982) 2.06
Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J Clin Invest (1973) 2.04
Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med (1986) 2.01
Insulin resistance in uremia. J Clin Invest (1981) 1.98
Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med (1980) 1.96
Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol (1996) 1.94
Retracted Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest (1979) 1.94
Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res (1998) 1.92
Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A (1999) 1.91
The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes (1985) 1.88
Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med (1979) 1.88
Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest (1975) 1.87
Plasma amino acid levels in diabetic ketoacidosis. Diabetes (1970) 1.76
Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. J Clin Invest (1995) 1.76
Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology (1998) 1.75
Retracted Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest (1978) 1.73
Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest (1974) 1.73
Fuel homeostasis in exercise. N Engl J Med (1975) 1.73
Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes (1975) 1.68
Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest (1972) 1.63
Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med (2000) 1.63
Evidence of inter-organ amino-acid transport by blood cells in humans. Proc Natl Acad Sci U S A (1973) 1.60
Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest (1981) 1.59
Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes (1978) 1.58
Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest (1995) 1.58
Simulation and evaluation of nicotine intake during passive smoking: cotinine measurements in body fluids of nonsmokers given intravenous infusions of nicotine. Clin Pharmacol Ther (1990) 1.52
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia (2008) 1.50
The effect of local anaesthetics on the central circulation and respiration in man and dog. Acta Anaesthesiol Scand (1968) 1.50
The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia (1992) 1.47
Infusion of ornithine-alpha-ketoglutarate in healthy subjects: effects on protein metabolism. Clin Nutr (1985) 1.47
Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med (1976) 1.46
Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes (1980) 1.46
Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus. J Clin Invest (1975) 1.46
Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab (1994) 1.44
Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem (1991) 1.43
Influence of age on the local circulatory adaptation to leg exercise. Scand J Clin Lab Invest (1974) 1.43
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol (1983) 1.43
Hypoglycemia during prolonged exercise in normal men. N Engl J Med (1982) 1.42
Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endocrinol Metab (1978) 1.41
Very-low-calorie protein diets. N Engl J Med (1984) 1.40
Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. J Biol Chem (1991) 1.38
Proinsulin C-peptide--a consensus statement. Int J Exp Diabetes Res (2001) 1.38
Beta-adrenergic blockade does not influence the thermogenic response to a mixed meal in man. Clin Physiol (1989) 1.38
Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab (1981) 1.37
[Starvation in human pregnancy: hypoglycemia, hypoinsulinemia, and hyperketonemia]. Science (1970) 1.36